isoniazid has been researched along with Infection, Mycobacterium avium-intracellulare in 25 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "avium bacteremia in patients with AIDS and disseminated infection." | 6.67 | Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. ( Berlie, HC; Chevret, S; Dautzenberg, B; Grosset, J; Legris, S; Mercat, A; Meyohas, MC; Truffot, C, 1991) |
| "The aims of this study were to (1) identify trends and risk factors for mycobacterial disease and (2) determine the effect of expanded access to isoniazid chemoprophylaxis on tuberculosis incidence." | 5.08 | Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. ( Astemborski, J; Bonds, M; Galai, N; Graham, NM; Nelson, KE; Rizzo, RT; Sheeley, L; Vlahov, D, 1996) |
| "avium bacteremia in patients with AIDS and disseminated infection." | 2.67 | Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. ( Berlie, HC; Chevret, S; Dautzenberg, B; Grosset, J; Legris, S; Mercat, A; Meyohas, MC; Truffot, C, 1991) |
| "The prophylaxis of tuberculosis is cost-effective in that it prevents hospitalizations and eliminates the need for multidrug treatment of active disease." | 1.29 | Prophylaxis of mycobacterial infections in immunocompromised patients. ( Fisher, MA; Krance, MB, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 15 (60.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vavříková, E | 1 |
| Polanc, S | 1 |
| Kočevar, M | 1 |
| Košmrlj, J | 1 |
| Horváti, K | 1 |
| Bosze, S | 1 |
| Stolaříková, J | 1 |
| Imramovský, A | 1 |
| Vinšová, J | 1 |
| Fahel, JS | 1 |
| Vieira, RP | 1 |
| Marinho, FV | 1 |
| Santos, VC | 1 |
| de Assis, JV | 1 |
| Corsetti, PP | 1 |
| Ferreira, RS | 1 |
| de Almeida, MV | 1 |
| Oliveira, SC | 1 |
| Cuesta Hernández, M | 1 |
| Gómez Hoyos, E | 1 |
| Agrela Rojas, E | 1 |
| Téllez Molina, MJ | 1 |
| Díaz Pérez, JÁ | 1 |
| Pourshahab, PS | 1 |
| Gilani, K | 1 |
| Moazeni, E | 1 |
| Eslahi, H | 1 |
| Fazeli, MR | 1 |
| Jamalifar, H | 1 |
| Massongo, M | 1 |
| Pasquet, A | 1 |
| Huleux, T | 1 |
| Aïssi, E | 1 |
| Ettahar, N | 1 |
| Yazdanpanah, Y | 1 |
| Melliez, H | 1 |
| Nagai, H | 1 |
| Reddy, MV | 1 |
| Srinivasan, S | 1 |
| Gangadharam, PR | 1 |
| Olliaro, P | 2 |
| Dautzenberg, B | 2 |
| Giacchino, R | 1 |
| Tasso, L | 1 |
| Losurdo, G | 1 |
| Castagnola, E | 1 |
| Regnard, PJ | 1 |
| Barry, P | 1 |
| Isselin, J | 1 |
| Graham, NM | 1 |
| Galai, N | 1 |
| Nelson, KE | 1 |
| Astemborski, J | 1 |
| Bonds, M | 1 |
| Rizzo, RT | 1 |
| Sheeley, L | 1 |
| Vlahov, D | 1 |
| Fisher, M | 1 |
| Tomlinson, DR | 1 |
| Coker, RJ | 1 |
| Krance, MB | 1 |
| Fisher, MA | 1 |
| Peloquin, CA | 1 |
| Berning, SE | 1 |
| Marklund, BI | 1 |
| Mahenthiralingam, E | 1 |
| Stokes, RW | 1 |
| Bowersox, J | 1 |
| Truffot, C | 1 |
| Legris, S | 1 |
| Meyohas, MC | 1 |
| Berlie, HC | 1 |
| Mercat, A | 1 |
| Chevret, S | 1 |
| Grosset, J | 1 |
| Tsukamura, M | 2 |
| Kuze, F | 1 |
| Hoy, J | 1 |
| Mijch, A | 1 |
| Sandland, M | 1 |
| Grayson, L | 1 |
| Lucas, R | 1 |
| Dwyer, B | 1 |
| Ichiyama, S | 1 |
| Miyachi, T | 1 |
| Agins, BD | 1 |
| Berman, DS | 1 |
| Spicehandler, D | 1 |
| el-Sadr, W | 1 |
| Simberkoff, MS | 1 |
| Rahal, JJ | 1 |
1 review available for isoniazid and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
[Nontuberculous mycobacteriosis].
Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; M | 2003 |
4 trials available for isoniazid and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Body Burden; Clofazimine; Drug Therapy, Combinat | 1994 |
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotic Prophylaxis; Antitubercular Agents; Female; | 1996 |
Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Multi | 2002 |
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Colony Count, Microbial; Double-Blind Met | 1991 |
20 other studies available for isoniazid and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cell Survival; Hep G2 Cells; Humans; Hydrazones; Isoni | 2011 |
JVA, an isoniazid analogue, is a bioactive compound against a clinical isolate of the Mycobacterium avium complex.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Hydrazones; Isoniazid; Macrophages; Mice, Inbr | 2019 |
[Thyroid tuberculosis; a rare cause of compressive goiter].
Topics: Antitubercular Agents; Biopsy; Combined Modality Therapy; Deglutition Disorders; Drainage; Ethambuto | 2013 |
Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
Topics: Administration, Inhalation; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Chitosan; Dr | 2011 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, High | 2011 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC).
Topics: AIDS-Related Opportunistic Infections; Animals; Clofazimine; Colony Count, Microbial; Dose-Response | 1994 |
Safety of rifabutin in a three-month-old infant.
Topics: Amikacin; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Mycobacterium av | 1994 |
Mycobacterial tenosynovitis of the flexor tendons of the hand. A report of five cases.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Carpal Tunnel Syndrome; Combined Mo | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitu | 1996 |
Prophylaxis of mycobacterial infections in immunocompromised patients.
Topics: Algorithms; Antitubercular Agents; Humans; Immunocompromised Host; Isoniazid; Mycobacterium avium-in | 1996 |
Advice on treatment of Mycobacterium avium complex infection.
Topics: Antitubercular Agents; Clarithromycin; Drug Interactions; Humans; Isoniazid; Mycobacterium avium Com | 1997 |
Site-directed mutagenesis and virulence assessment of the katG gene of Mycobacterium intracellulare.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Base Sequence; Cloning, Molecular; DNA Probes; D | 1998 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifung | 1996 |
[Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Topics: Adult; Aged; Drug Therapy, Combination; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Kanamycin | 1991 |
[Drug therapy of intractable Mycobacterium infections].
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium | 1990 |
Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Clofazimine; Drug Therapy, Combina | 1990 |
Superiority of enviomycin or streptomycin over ethambutol in initial treatment of lung disease caused by Mycobacterium avium complex.
Topics: Clinical Protocols; Drug Combinations; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Lung Disea | 1989 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combinati | 1989 |
Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anti-Bacterial Agents; Antitubercular Agen | 1989 |